Citation Impact
Citing Papers
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Breast Cancer Metastasis to the Central Nervous System
2005
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Lapatinib
2007
Breast cancer
2019 Standout
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
2015 StandoutNobel
New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes
2017
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Prognostic Significance of Human Epidermal Growth Factor Receptor Positivity for the Development of Brain Metastasis After Newly Diagnosed Breast Cancer
2006
Primary breast cancer phenotypes associated with propensity for central nervous system metastases
2006
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
2009 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Breast cancer
2016 Standout
Potential Effect of Robust and Simple IMRT Approach for Left-Sided Breast Cancer on Cardiac Mortality
2008
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR
2006
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
2009 Standout
Genetics and genomics of radiotherapy toxicity: towards prediction
2011
Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes
2003
Cushing's syndrome
2015 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Estimating the optimal external‐beam radiotherapy utilization rate for genitourinary malignancies
2004
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Conformity index: A review
2006 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer
2007
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
L'effet volume en radiothérapie première partie : effet volume et tumeur
2003
Malignant Gliomas in Adults
2008 Standout
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Regulation of Vascularization by Hypoxia‐Inducible Factor 1
2009 StandoutNobel
Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?
2005
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Factors affecting the prognosis of breast cancer patients with brain metastases
2008
Cancer-related inflammation and treatment effectiveness
2014 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)
2010
Sagopilone crosses the blood–brain barrier in vivo to inhibit brain tumor growth and metastases
2008
Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
2014
The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis
2014
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Larotaxel: broadening the road with new taxanes
2009
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Trastuzumab in the management of early and advanced stage breast cancer.
2007
Timing and duration of 5-HT3 receptor antagonist therapy for the prophylaxis of radiotherapy-induced nausea and vomiting: a systematic review of randomized and non-randomized studies
2012
The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer
2013
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Efficacy of Adjuvant Radiotherapy of the Tumor Bed on Local Recurrence of Adrenocortical Carcinoma
2006
The role of radiotherapy in cancer treatment
2005 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Adrenocortical Carcinoma
2013
Accelerated partial breast irradiation: Current status with a focus on clinical practice
2018
Lapatinib: Current Status and Future Directions in Breast Cancer
2006
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Works of B. Magee being referenced
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
2004
Adrenal cortical carcinoma: Survival after radiotherapy
1987
Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial
1996
The antiemetic effect of granisetron in lower hemibody radiotherapy
1991
The treatment of advanced seminoma with chemotherapy and radiotherapy
1988
Local Recurrence of Breast Cancer Following Surgery and Radiotherapy: Incidence and Outcome
2003
Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients
2003
Abstract S4-1: The UK START (Standardisation of Breast Radiotherapy) Trials: 10-year follow-up results
2012
Use of electronic portal imaging to assess cardiac irradiation in breast radiotherapy
1997
Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients
2003